How Agentic AI Could Slash Healthcare Revenue Cycle Costs by Up to 60%

Report Overview

In January 2026 McKinsey released the report Agentic AI and the race to a touchless revenue cycle , focusing on the long‑standing pain points of Revenue Cycle Management (RCM) in the U.S. healthcare system—high cost, low efficiency, and frequent claim rejections.

Why Agentic AI Matters

Agentic AI, a next‑generation autonomous AI, can lower RCM costs by 30 %–60 % , speed up cash collection, improve payment accuracy, and free staff from repetitive administrative tasks so they can focus on higher‑value clinical services and patient experience.

Scale of the Problem

The U.S. healthcare system spends over $1.4 trillion annually on RCM, representing 3 %–4 % of revenue for large providers. Inefficiencies stem from manual processes, fragmented vendor systems, and outdated technology. About 20 % of bills are denied, and 60 % of those denials are never appealed, causing millions of dollars in lost revenue.

Agentic AI vs. Traditional Generative AI

Traditional generative AI only offers suggestions, whereas Agentic AI can make autonomous decisions and execute end‑to‑end complex workflows, acting more like a colleague than a simple tool.

Strategic Recommendation: Start from the Backend

McKinsey advises a backend‑first approach to achieve a truly “touchless” revenue cycle. The backend includes accounts receivable follow‑up, delinquency management, denial management, and cash posting—areas with clear rules, high labor intensity, and low patient‑impact risk.

Labor‑intensive, rule‑clear : Tasks are predictable; Agentic AI can handle most work, leaving humans to manage exceptions.

Incremental rollout : Implement use cases one by one (e.g., automate denial management first, then expand to collections).

Low‑risk testing ground : Backend processes are administrative, so compliance is easier and patient experience is unaffected.

Pathway to full transformation : Success in the backend builds trust for later front‑ and mid‑end automation (scheduling, clinical documentation).

Four Practical Implementation Guidelines

Start with a proof‑of‑concept, avoid pilot paralysis – Run a small‑scale pilot, set clear success metrics (e.g., denial reversal rate, days sales outstanding), then scale quickly across the organization.

Decide between build, buy, or partner – Choose the model that fits strategic goals; many institutions adopt a hybrid approach to retain IP while leveraging external speed and scale.

Prioritize high‑impact, high‑error processes – Target workflows with the greatest financial loss and measurable outcomes, such as denial appeals and receivable acceleration.

Focus on people and change management – Emphasize AI as an augmentative tool, train staff to handle exceptions, and consider establishing an AI Center of Excellence to coordinate product, data science, and operations talent.

Projected Financial Impact

For a hospital with $6 billion annual patient revenue, a 1–2 percentage‑point reduction in RCM cost (from 3.5 %–4 % to 1.5 %–2 %) translates to annual savings of $60 million–$120 million . Early indicators such as denial rates, bad‑debt ratios, and days sales outstanding can quickly show progress.

Conclusion

The healthcare industry has long awaited a disruptive shift in RCM. Agentic AI promises a “touchless” revenue cycle, where human staff remain in the loop for compliance and complex decision‑making while AI handles routine, high‑volume tasks. Early adopters that move quickly will secure a competitive advantage in cost efficiency and patient satisfaction.